1. Discuss the use of GLP-1 agonists for weight management in patients with ESRD. Identify the optimal weight loss intervention for improving access to kidney transplantation in patients with ESRD and obesity. Identify and discuss the impact of different weight loss interventions on long-term survival in patients with ESRD and obesity. Demonstrate how Markov decision models provide a framework to evaluate multiple weight loss interventions in a complex population
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
This is a journal-based activity. Credit is earned after completing the required reading and assessment; the amount shown is the provider-reported available credit.
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 14407 SW 2nd Place
Specialties served/covered
- No reviews yet. Be the first to share yours.



